IL78938A - Pharmaceutical composition containing lyophilized tissue plasminogen activator and its preparation - Google Patents

Pharmaceutical composition containing lyophilized tissue plasminogen activator and its preparation

Info

Publication number
IL78938A
IL78938A IL78938A IL7893886A IL78938A IL 78938 A IL78938 A IL 78938A IL 78938 A IL78938 A IL 78938A IL 7893886 A IL7893886 A IL 7893886A IL 78938 A IL78938 A IL 78938A
Authority
IL
Israel
Prior art keywords
preparation
pharmaceutical composition
composition containing
plasminogen activator
tissue plasminogen
Prior art date
Application number
IL78938A
Other languages
English (en)
Other versions
IL78938A0 (en
Original Assignee
Wellcome Found
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from GB858513358A external-priority patent/GB8513358D0/en
Priority claimed from GB858521705A external-priority patent/GB8521705D0/en
Application filed by Wellcome Found filed Critical Wellcome Found
Publication of IL78938A0 publication Critical patent/IL78938A0/xx
Publication of IL78938A publication Critical patent/IL78938A/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/14—Hydrolases (3)
    • C12N9/48—Hydrolases (3) acting on peptide bonds (3.4)
    • C12N9/50—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25)
    • C12N9/64—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25) derived from animal tissue
    • C12N9/6421—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25) derived from animal tissue from mammals
    • C12N9/6424—Serine endopeptidases (3.4.21)
    • C12N9/6456—Plasminogen activators
    • C12N9/6459—Plasminogen activators t-plasminogen activator (3.4.21.68), i.e. tPA
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Y—ENZYMES
    • C12Y304/00—Hydrolases acting on peptide bonds, i.e. peptidases (3.4)
    • C12Y304/21—Serine endopeptidases (3.4.21)
    • C12Y304/21069—Protein C activated (3.4.21.69)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Organic Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Wood Science & Technology (AREA)
  • Zoology (AREA)
  • Genetics & Genomics (AREA)
  • General Health & Medical Sciences (AREA)
  • Biochemistry (AREA)
  • General Engineering & Computer Science (AREA)
  • Biomedical Technology (AREA)
  • Medicinal Chemistry (AREA)
  • Microbiology (AREA)
  • Biotechnology (AREA)
  • Molecular Biology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Hematology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Diabetes (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicinal Preparation (AREA)
  • Enzymes And Modification Thereof (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
IL78938A 1985-05-28 1986-05-27 Pharmaceutical composition containing lyophilized tissue plasminogen activator and its preparation IL78938A (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GB858513358A GB8513358D0 (en) 1985-05-28 1985-05-28 Formulation
GB858521705A GB8521705D0 (en) 1985-08-31 1985-08-31 Formulation

Publications (2)

Publication Number Publication Date
IL78938A0 IL78938A0 (en) 1986-09-30
IL78938A true IL78938A (en) 1993-02-21

Family

ID=26289290

Family Applications (1)

Application Number Title Priority Date Filing Date
IL78938A IL78938A (en) 1985-05-28 1986-05-27 Pharmaceutical composition containing lyophilized tissue plasminogen activator and its preparation

Country Status (22)

Country Link
US (2) US4929444A (fr)
JP (1) JPH0759517B2 (fr)
AU (1) AU567236B2 (fr)
BE (1) BE904830A (fr)
CA (1) CA1300008C (fr)
CH (1) CH665356A5 (fr)
DE (1) DE3617752A1 (fr)
DK (1) DK163173C (fr)
ES (2) ES8800601A1 (fr)
FI (1) FI85335C (fr)
FR (1) FR2583984B1 (fr)
GB (1) GB2176702B (fr)
GR (1) GR861366B (fr)
HU (1) HU195733B (fr)
IL (1) IL78938A (fr)
IT (1) IT1191926B (fr)
LU (1) LU86444A1 (fr)
NL (1) NL8601355A (fr)
NO (1) NO171345C (fr)
NZ (1) NZ216307A (fr)
PT (1) PT82646B (fr)
SE (1) SE462016B (fr)

Families Citing this family (25)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IL78937A (en) * 1985-05-28 1990-11-29 Wellcome Found Pharmaceutical compositions containing tissue-plasminogen activator
ZW14486A1 (en) * 1985-07-29 1986-10-22 Smithkline Beckman Corp Pharmaceutical dosage unit
US5034225A (en) * 1985-12-17 1991-07-23 Genentech Inc. Stabilized human tissue plasminogen activator compositions
US4777043A (en) * 1985-12-17 1988-10-11 Genentech, Inc. Stabilized human tissue plasminogen activator compositions
IE59895B1 (en) * 1986-05-12 1994-04-20 Wellcome Found Medicaments containing tissue plasminogen activator
US4976959A (en) * 1986-05-12 1990-12-11 Burroughs Wellcome Co. T-PA and SOD in limiting tissue damage
GB8619098D0 (en) * 1986-08-05 1986-09-17 Wellcome Found Combination
US5270198A (en) * 1988-05-20 1993-12-14 Genentech, Inc. DNA molecules encoding variants of tissue plasminogen activators, vectors, and host cells
US5342616A (en) * 1988-06-20 1994-08-30 The Wellcome Foundation Limited Method of administering tissue plasminogen activator
US5262170A (en) * 1988-09-02 1993-11-16 Genentech, Inc. Tissue plasminogen activator having zymogenic or fibrin specific properties and substituted at amino acid positions 296-299, DNA molecules encoding them, vectors, and host cells
US5714145A (en) * 1988-09-02 1998-02-03 Genentech, Inc. Tissue plasminogen activator having zymogenic or fibrin specific properties
DE3835350A1 (de) * 1988-10-17 1990-04-19 Boehringer Mannheim Gmbh Aktivierung von gentechnologisch hergestellten, in prokaryonten exprimierten antikoerpern
US4980165A (en) * 1989-01-27 1990-12-25 Genetics Institute, Inc. Pharmaceutical formulations of plasminogen activator proteins
DE3942142A1 (de) * 1989-12-20 1991-06-27 Boehringer Mannheim Gmbh Stabilisierung von glykosyliertem t-pa
WO1992011866A1 (fr) * 1991-01-14 1992-07-23 Duke University SEQUENCE DE LAMININE UTILES COMME ACTIVATEUR DE tPA
ATE246000T1 (de) * 1992-06-03 2003-08-15 Genentech Inc Varianten des gewebeplasminogenaktivators mit verbesserter therapeutischer wirkung
DE69629826T2 (de) * 1995-10-23 2004-07-01 Children's Medical Center Corp., Boston Therapeutische antiangiogenische zusammensetzungen und verfahren
US6346510B1 (en) 1995-10-23 2002-02-12 The Children's Medical Center Corporation Therapeutic antiangiogenic endostatin compositions
DE69631972T2 (de) * 1995-12-13 2005-01-05 The Children's Medical Center Corp., Boston Proliferationsinhibitor von endothellzellen und dessen verwendung
DE69719265T2 (de) * 1996-09-06 2003-12-04 Juridical Foundation The Chemo-Sero-Therapeutic Research Institute, Kumamoto Medizinische Zusammensetzung die Gewebeplasminogenaktivator und Nikotinamid enthält
EP1432437A2 (fr) * 2001-09-07 2004-06-30 Global Biotech Inc. Formulation contenant un activateur de plasminogene de type urokinase de tissu humain
US20040091465A1 (en) * 2002-06-26 2004-05-13 Zachary Yim Therapeutic antiangiogenic compositions and methods
AU2004253882B2 (en) * 2003-06-20 2010-06-10 Illumina, Inc. Methods and compositions for whole genome amplification and genotyping
US7491263B2 (en) * 2004-04-05 2009-02-17 Technology Innovation, Llc Storage assembly
PT1879599E (pt) * 2005-04-20 2014-01-23 Hutchinson Fred Cancer Res Métodos, composições e artigos de fabrico para aumentar a capacidade de sobrevivência de células, tecidos, órgãos, e organismos

Family Cites Families (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3998947A (en) * 1973-11-30 1976-12-21 Pierre Fabre S.A. Process for obtaining a plasminogen activator
FR2252842B1 (fr) * 1973-12-03 1977-11-04 Fabre Sa Pierre
DE3015699C2 (de) * 1979-04-26 1982-07-15 Asahi Kasei Kogyo K.K., Osaka Herstellung eines Plasminogen-Aktivators
US4766075A (en) * 1982-07-14 1988-08-23 Genentech, Inc. Human tissue plasminogen activator
JPS5951220A (ja) * 1982-08-02 1984-03-24 Asahi Chem Ind Co Ltd 新規なプラスミノ−ゲン・アクチベ−タ−およびその製法ならびにこれを含有する薬剤
WO1984001714A1 (fr) * 1982-10-29 1984-05-10 Mitsui Toatsu Chemicals Nouvel activateur de plasminogene, son procede de preparation et medicament thrombolytique le contenant
AU554862B2 (en) * 1982-12-14 1986-09-04 Implico B.V. Plasminogen activator isolated by affinity chromatography
NZ206699A (en) * 1982-12-30 1989-08-29 Bio Response Inc Process for the production of serum independent cell lines
JPS59196824A (ja) * 1983-04-21 1984-11-08 Kowa Co 吸着防止剤
DE3584902D1 (de) * 1984-02-29 1992-01-30 Asahi Chemical Ind Waessrige loesung eines darin in erhoehter konzentration aufgeloesten gewebe-plasminogen-aktivators und herstellungsverfahren.
DE3439980A1 (de) * 1984-11-02 1986-05-07 Behringwerke Ag, 3550 Marburg Verfahren zur reinigung sowie pasteurisierung von urokinase
EP0201153A3 (fr) * 1985-02-09 1987-10-07 Beecham Group Plc Enzyme modifié et son procédé de préparation
GB8513358D0 (en) * 1985-05-28 1985-07-03 Wellcome Found Formulation
ZW14486A1 (en) * 1985-07-29 1986-10-22 Smithkline Beckman Corp Pharmaceutical dosage unit
JPH0672105B2 (ja) * 1985-10-02 1994-09-14 持田製薬株式会社 血栓溶解剤及びその製法

Also Published As

Publication number Publication date
FI85335C (fi) 1992-04-10
NZ216307A (en) 1989-10-27
SE8602405L (sv) 1986-11-29
IT1191926B (it) 1988-03-31
JPH0759517B2 (ja) 1995-06-28
FI862227A (fi) 1986-11-29
DK163173B (da) 1992-02-03
ES555353A0 (es) 1987-11-16
BE904830A (fr) 1986-11-27
FR2583984B1 (fr) 1989-06-02
GR861366B (en) 1986-09-29
DK246786A (da) 1986-11-29
IT8648065A0 (it) 1986-05-27
DE3617752A1 (de) 1986-12-04
GB2176702B (en) 1989-07-05
ES8800601A1 (es) 1987-11-16
SE8602405D0 (sv) 1986-05-27
GB8612780D0 (en) 1986-07-02
US4968617A (en) 1990-11-06
DK246786D0 (da) 1986-05-27
CA1300008C (fr) 1992-05-05
IL78938A0 (en) 1986-09-30
NL8601355A (nl) 1986-12-16
NO171345B (no) 1992-11-23
AU5796486A (en) 1986-12-04
DK163173C (da) 1992-06-22
ES557374A0 (es) 1988-06-01
LU86444A1 (fr) 1986-12-05
PT82646A (en) 1986-06-01
ES8802439A1 (es) 1988-06-01
US4929444A (en) 1990-05-29
FI862227A0 (fi) 1986-05-27
NO171345C (no) 1993-03-03
FI85335B (fi) 1991-12-31
PT82646B (pt) 1989-01-30
HUT41638A (en) 1987-05-28
FR2583984A1 (fr) 1987-01-02
JPH06183995A (ja) 1994-07-05
GB2176702A (en) 1987-01-07
AU567236B2 (en) 1987-11-12
SE462016B (sv) 1990-04-30
NO862096L (no) 1986-12-01
CH665356A5 (de) 1988-05-13
DE3617752C2 (fr) 1988-06-30
HU195733B (en) 1988-07-28

Similar Documents

Publication Publication Date Title
IL78938A (en) Pharmaceutical composition containing lyophilized tissue plasminogen activator and its preparation
NZ216306A (en) Pharmaceutical compositions containing tissue plasminogen activator
IL79235A (en) Pharmaceutical compositions containing solubilized proteins and their preparation
GB2221390B (en) Niacin-containing composition and its therapeutic use
IL82221A0 (en) Phenyl-piperazines and pharmaceutical compositions containing them
NZ216793A (en) Phenethanolaminotetraline derivatives and pharmaceutical compositions
GB2181346B (en) Pharmaceutical compositions and medical uses of dioxopiperidine derivatives
EP0196920A3 (en) Degraded species of tissue-type plasminogen activator, pharmaceutical composition and method of preparation
NZ220020A (en) 1-hydroxy-2-pyridones and pharmaceutical composition
IL79376A (en) Substituted di-t-butylphenols and pharmaceutical compositions containing them
NZ214821A (en) Spiro-dioxolanes, -dithiolanes and -oxothiolanes and pharmaceutical compositions
IL86711A0 (en) 5-pyrimidinecarboxamide derivatives and pharmaceutical compositions containing them
NZ217078A (en) N-piperidyl-benzamide derivatives and pharmaceutical compositions
NZ215070A (en) Imidazole-indoles and pharmaceutical compositions
PT83279A (en) Process for the preparation of peptide antibiotics and of pharmaceutical compositions therewith
NZ216720A (en) Diazinylpiperidine derivatives and pharmaceutical compositions
IL79003A0 (en) Tetrahydroimidazoquinazolinones and pharmaceutical compositions containing them
NZ216438A (en) Steroid-pyrazoles and pharmaceutical compositions
NZ214815A (en) 12-aminopyridazinopyrroloisoquinoline derivatives and pharmaceutical compositions
ZA863956B (en) Pharmaceutical formulations containing tissue plasminogen activator
IL78918A (en) Spiroheterocyclically-condensed hexahydroaryl-quinolizines and pharmaceutical compositions containing them
IL92650A0 (en) Polyhydroxybenzyloxypropanolamides and pharmaceutical compositions containing them
IL79377A0 (en) Substituted di-t-butylphenols and pharmaceutical compositions containing them
NZ215936A (en) Rioprostil - pvp complex and pharmaceutical compositions
IL79535A0 (en) Acylphosphorotriamides and pharmaceutical compositions containing them

Legal Events

Date Code Title Description
RH Patent void